Cargando…

Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies

There is mounting evidence that in the absence of neutralizing antibodies cross-reactive T cells provide protection against pandemic influenza viruses. Here, we compared protection and CD8+ T cell responses following challenge with H1N1 2009 pandemic and H3N2 viruses of mice that had been immunized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schotsaert, Michael, Ysenbaert, Tine, Smet, Anouk, Schepens, Bert, Vanderschaeghe, Dieter, Stegalkina, Svetlana, Vogel, Thorsten U., Callewaert, Nico, Fiers, Walter, Saelens, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829898/ https://www.ncbi.nlm.nih.gov/pubmed/27072615 http://dx.doi.org/10.1038/srep24402

Ejemplares similares

Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase
por: Catani, João Paulo Portela, et al.
Publicado: (2022)

Anti-neuraminidase and anti-hemagglutinin immune serum can confer inter-lineage cross protection against recent influenza B
por: Portela Catani, João Paulo, et al.
Publicado: (2023)

Antibodies directed towards neuraminidase restrict influenza virus replication in primary human bronchial epithelial cells
por: Smet, Anouk, et al.
Publicado: (2022)

A GFP Expressing Influenza A Virus to Report In Vivo Tropism and Protection by a Matrix Protein 2 Ectodomain-Specific Monoclonal Antibody
por: De Baets, Sarah, et al.
Publicado: (2015)

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
por: Job, E. R., et al.
Publicado: (2019)

Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs
por: Job, E. R., et al.
Publicado: (2018)

Controlling Influenza by Cytotoxic T-Cells: Calling for Help from Destroyers
por: Schotsaert, Michael, et al.
Publicado: (2010)

Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies
por: Oltean, Teodora, et al.
Publicado: (2022)

Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice
por: Joe, Patrick Tjok, et al.
Publicado: (2019)

M2e-Displaying Virus-Like Particles with Associated RNA Promote T Helper 1 Type Adaptive Immunity against Influenza A
por: Ibañez, Lorena Itatí, et al.
Publicado: (2013)

Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e
por: Kammoun, Hana, et al.
Publicado: (2013)

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein
por: Schepens, Bert, et al.
Publicado: (2014)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Creytens, Sarah, et al.
Publicado: (2021)

M2e-Based Universal Influenza A Vaccines
por: Deng, Lei, et al.
Publicado: (2015)

IgG3 Snitcher of RSV Infections in the Very Young
por: Schepens, Bert, et al.
Publicado: (2017)

Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses
por: Sedeyn, Koen, et al.
Publicado: (2019)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Super-resolution microscopy reveals significant impact of M2e-specific monoclonal antibodies on influenza A virus filament formation at the host cell surface
por: Kolpe, Annasaheb, et al.
Publicado: (2019)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

TIV Vaccination Modulates Host Responses to Influenza Virus Infection that Correlate with Protection against Bacterial Superinfection
por: Choi, Angela, et al.
Publicado: (2019)

Single-Domain Antibodies and Their Formatting to Combat Viral Infections
por: De Vlieger, Dorien, et al.
Publicado: (2018)

How RSV Proteins Join Forces to Overcome the Host Innate Immune Response
por: Van Royen, Tessa, et al.
Publicado: (2022)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Influenza Virus Neuraminidase: Structure and Function
por: Shtyrya, Y.A., et al.
Publicado: (2009)

Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010)

Influenza Virus Neuraminidase Structure and Functions
por: McAuley, Julie L., et al.
Publicado: (2019)

Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor
por: Nishikawa, Tomoko, et al.
Publicado: (2012)

Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages
por: Deng, Lei, et al.
Publicado: (2015)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
por: Wrapp, Daniel, et al.
Publicado: (2020)

Mechanism of 150-cavity formation in influenza neuraminidase
por: Amaro, Rommie E., et al.
Publicado: (2011)

Systematic review of influenza resistance to the neuraminidase inhibitors
por: Thorlund, Kristian, et al.
Publicado: (2011)

The role of neuraminidase inhibitors in the treatment and prevention of influenza
por: Naem, Shahrour
Publicado: (2001)

Exploring the chemical space of influenza neuraminidase inhibitors
por: Anuwongcharoen, Nuttapat, et al.
Publicado: (2016)

Aurintricarboxylic acid inhibits influenza virus neuraminidase
por: Hung, Hui-Chen, et al.
Publicado: (2009)

Inherent Serum Inhibition of Influenza Virus Neuraminidases
por: Skarlupka, Amanda L., et al.
Publicado: (2021)

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
por: Van den Hoecke, Silvie, et al.
Publicado: (2021)

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
por: Van Hoecke, Lien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6u8j24c2tfgaf7urd8mm2a5u2i